The effects of 3-glucosaminoglycan sulfate on lipids and the hemorheologic parameters were observed in a preliminary double-blind crossover study in 30 hyperlipidemic peripheral vascular disease (PVD) patients. Parenteral adminis tration of the test drug was associated with a reduction in serum lipids, espe cially in triglyceride levels, and a lowering of fibrinogen, plasma viscosity, and whole blood viscosity levels. These effects justify the drug's use in the treatment of PVD, especially when associated with hypertriglyceridemia and hemorheo logic disturbances.
Get full access to this article
View all access options for this article.
References
1.
Mancini G., Dall'Asta D., Maini C., et al: Prevenzione e terapia con 3GS degli attacchi ischemici cerebrali transitori nell'anziano. G Clin Med64:51-54, 1983.
2.
Sozzi C.: The preventive activity of an extractive glycosaminoglycan in relapses of TIA. A short term study. Eur Rev MedPharmacol Sci6:295-297, 1984.
3.
Bartolo M., Antignani PL, Eleuteri P.: Experiences with Sulodexide in the arterial peripheral disease. Curr Ther Res36:979-983, 1986.
4.
Di Perri T., Laghi Pasini F., Guerrini M., et al: Azione della infusione e.v. di glucosamin-glicansolfato sulle frazioni lipidiche e sulla viscosità ematica in un gruppo di soggetti con vasculopatia distrettuale acuta. G Arterioscl3:41-44, 1978.
5.
Beaumont JL, Carlson LA, Cooper GR, et al: Classification of hyperlipidemias and hyperlipoproteinemias . Bull WHO43:891-895, 1970.
6.
Roschlau P., Bernt E., Gruber W.: Enzymatische Bestimmung des Gesamtcholesterins im Serum. Z Klin Chem12:403-406, 1974.
7.
Wahlefel AW: Triglyceride determination after enzymatic hydrolysis. In: Methoden der Enzymatischen Analyse, ed. by Bergmeyer HU, Weinheim. Verlag Chemie, 2:1878-1882, 1974 .
8.
Mancini G., Carbonara AO, Heremans JF: Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry2:235-236, 1965.
9.
Wells RE Jr, Denton R., Merril EW: Measurement of viscosity of biological fluids by cone-plate viscosimeter. J Lab Clin Med57:646-648, 1961.
10.
Reid HL, Barnes AJ, Lock PJ, et al: A simple method for measuring erythrocyte deformability. J Clin Pathol29:855-858, 1976.
11.
Avogaro P., Bittolo Bon G., Taroni GC, et al: Effect of the extractive heparinoid, glucuronyl-glucosaminglycan sulfate (3GS), on human plasma lipids. Pharm Res Comm9:977-980, 1977.
12.
Hoffman J.: Glukoronil-glycosamin-glycansulfat in der behandlung der hyperlipaemie. Ther Woche28:9165-9168, 1978.
13.
Saba P., Galeone F., Pagliai E., et al: Clinical investigation on efficacy of extractive glucurono-glucosaminoglycan sulphate in cases of hyperlipidemia. Curr Ther Res28:535-538, 1980.
14.
Bertolini S. , Dealessi M., Elicio N., et al: Clinical evaluation of Sulodexide long term treatment in atherosclerotic dislipidemic patients. G ArterioscI1:45-48, 1985.
15.
Bell W.: The biosynthesis of fibrinogen: In vivo studies. In: Molecular Biology of Fibrinogen and Fibrin, ed. by Mosesson MW, Doolittle RF. Ann NY Acad Sci208:503-505, 1983.
16.
Comp PC: Heparin-protein C interaction. Nouv Rev Fr Hematol26:239-241, 1984.
17.
Lowe Gdo: Blood rheology in arterial disease. Clin Sci71:137-140, 1986.
